(Q73458742)

English

ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists

scientific article published on 01 November 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

based on heuristic

inferred from title

author name string

ACOG Committee on Practice Bulletins--Gynecology

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

International Journal of Gynecology and Obstetrics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

183-196

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Combined hysteroscopic and laparoscopic findings in patients with chronic pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

The relation of endometriosis to menstrual characteristics, smoking, and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Diagnosis and clinical presentation of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Fecundity of infertile women with minimal or mild endometriosis and women with unexplained infertility. The Canadian Collaborative Group on Endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Endometriosis and infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Mapping the source and character of pain due to endometriosis by patient-assisted laparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Laparoscopic appearances of peritoneal endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Subtle appearance of pelvic endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Unsuspected endometriosis documented by scanning electron microscopy in visually normal peritoneum

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa?

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Nonpigmented endometriosis: clinical, laparoscopic, and pathologic definition

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Elevated serum concentrations of CA-125 in patients with advanced endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Serum and peritoneal fluid CA-125 levels in patients with endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Serum and peritoneal lavage fluid CA-125 levels in endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

The use of CA-125 in the diagnosis and management of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Serum and peritoneal CA-125 levels as diagnostic test for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

The use of serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Serum CA 125 levels before, during and after treatment for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Magnetic resonance imaging characteristics of deep endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Revised American Society for Reproductive Medicine classification of endometriosis: 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Effects of triptorelin versus placebo on the symptoms of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

The efficacy of drugs in the management of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Progestins for symptomatic endometriosis: a critical analysis of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Recurrent endometriosis: a review of biological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

The impact of preoperative gonadotropin-releasing hormone agonist treatment on laparoscopic excision of ovarian endometriotic cysts.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Gonadotropin-releasing hormone agonists and the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

The role of laparoscopy in chronic pelvic pain: promise and pitfalls.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Is endometriosis a disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Recurrent endometriosis: incidence, management, and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Bilateral ureteric obstruction due to recurrent endometriosis associated with hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of symptom recurrence after hysterectomy for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2980034-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0020-7292(00)80034-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11186465%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73458742&oldid=1713744752"